Concepedia

Author

Toshiharu Komori

Taiho Pharmaceutical (Japan)

Also Known As

TOSHIHARU KOMORI, Toshiharu Komori, Toshiharu Komori (481309)

16

Publications

249

Citations

6

H-Index

13

Concepts

All Affiliations

Taiho Pharmaceutical (Japan)Tokyo Institute of Technology
TK

About

Toshiharu Komori is an author at Taiho Pharmaceutical (Japan) specializing in natural sciences, molecular biology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

85

2

Natural Sciences

1

1

85

3

Cell Biology

1

1

85

4

Molecular Biology

1

1

85

5

Developmental Biology

1

1

85

Toshiharu Komori

×

5

Publications

234

Citations

5

H-Index

YearCitations

Ash1l Methylates Lys36 of Histone H3 Independently of Transcriptional Elongation to Counteract Polycomb Silencing

Hitomi Miyazaki, Ken Higashimoto, Yukari Yada,

PLoS Genetics

2013

85

TAS6417/CLN-081 Is a Pan-Mutation–Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant <i>EGFR</i> Mutations

Hibiki Udagawa, Shinichi Hasako, Akihiro Ohashi,

Molecular Cancer Research

2019

70

Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use

Satoru Ito, Sachie Otsuki, Hirokazu Ohsawa,

ACS Medicinal Chemistry Letters

2023

31

Role of human transcription elongation factor DSIF in the suppression of senescence and apoptosis

Toshiharu Komori, Naoto Inukai, Tomoko Yamada,

Genes to Cells

2009

26

Schlafen11 Expression Is Associated With the Antitumor Activity of Trabectedin in Human Sarcoma Cell Lines

Junya Iwasaki, Toshiharu Komori, Fumio Nakagawa,

Anticancer Research

2019

22

Page 1